World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Immunology 70 2406 2210 1155 1050 333 18714
Medicine 72 19832 18599 9877 9102 345 19089

Richard B. Pollard publications per year

The chart shows the history of publications by Richard B. Pollard between 1973 and 2020, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Richard B. Pollard published across 48 years, from 1973 to 2020, averaging 7.3 papers a year. Output peaked at 20 publications in 2002. 6 of the 352 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1973 to 2020. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 2002. 1973: 1 publication 1974: 0 publications 1975: 3 publications 1976: 2 publications 1977: 1 publication 1978: 11 publications 1979: 3 publications 1980: 8 publications 1981: 8 publications 1982: 7 publications 1983: 2 publications 1984: 3 publications 1985: 6 publications 1986: 9 publications 1987: 4 publications 1988: 4 publications 1989: 4 publications 1990: 8 publications 1991: 13 publications 1992: 12 publications 1993: 9 publications 1994: 13 publications 1995: 13 publications 1996: 18 publications 1997: 14 publications 1998: 10 publications 1999: 11 publications 2000: 11 publications 2001: 11 publications 2002: 20 publications 2003: 10 publications 2004: 7 publications 2005: 9 publications 2006: 9 publications 2007: 7 publications 2008: 5 publications 2009: 10 publications 2010: 14 publications 2011: 4 publications 2012: 9 publications 2013: 8 publications 2014: 4 publications 2015: 2 publications 2016: 3 publications 2017: 5 publications 2018: 1 publication 2019: 4 publications 2020: 2 publications
1973 2020

352 publications in total across all disciplines

View publications per year as a table
Richard B. Pollard: publications per year, 1973 to 2020
Year Publications
1973 1
1974 0
1975 3
1976 2
1977 1
1978 11
1979 3
1980 8
1981 8
1982 7
1983 2
1984 3
1985 6
1986 9
1987 4
1988 4
1989 4
1990 8
1991 13
1992 12
1993 9
1994 13
1995 13
1996 18
1997 14
1998 10
1999 11
2000 11
2001 11
2002 20
2003 10
2004 7
2005 9
2006 9
2007 7
2008 5
2009 10
2010 14
2011 4
2012 9
2013 8
2014 4
2015 2
2016 3
2017 5
2018 1
2019 4
2020 2
Total 352
Download as CSV

Richard B. Pollard publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Richard B. Pollard sits on this spectrum.

No. of scientists
50 100 150
Bar chart with 76 bars. Horizontal axis: publications, 62–71 to 807+. Vertical axis: number of scientists, 0 to 189. Most scientists, 189, have 152–161 publications. The last bar groups every scientist with 807 publications or more. The highlighted bar, 332–341 publications, is where this scientist sits. 62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 69 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientist 807+ publications: 100 scientists
62–71 publications 807+

This scientist: 333 publications — 70th percentile

70% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

View publications distribution as a table
Number of Immunology scientists by publication count, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
Publications Scientists This scientist
62–71 9
72–81 23
82–91 40
92–101 72
102–111 86
112–121 108
122–131 150
132–141 160
142–151 159
152–161 189
162–171 166
172–181 181
182–191 188
192–201 187
202–211 178
212–221 158
222–231 168
232–241 159
242–251 160
252–261 148
262–271 116
272–281 125
282–291 115
292–301 111
302–311 95
312–321 97
322–331 97
332–341 99 333
342–351 96
352–361 69
362–371 76
372–381 71
382–391 71
392–401 62
402–411 54
412–421 41
422–431 63
432–441 53
442–451 31
452–461 42
462–471 40
472–481 29
482–491 34
492–501 30
502–511 23
512–521 41
522–531 29
532–541 28
542–551 16
552–561 18
562–571 18
572–581 17
582–591 17
592–601 17
602–611 19
612–621 13
622–631 12
632–641 11
642–651 16
652–661 9
662–671 5
672–681 13
682–691 12
692–701 6
702–711 6
712–721 9
722–731 9
732–741 6
742–751 11
752–761 10
762–771 7
772–781 12
782–791 7
792–801 5
802–806 1
807+ 100
Download as CSV

Richard B. Pollard D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Richard B. Pollard sits on this spectrum.

No. of scientists
50 100 150 200
Bar chart with 60 bars. Horizontal axis: D-Index, 40–41 to 157+. Vertical axis: number of scientists, 0 to 201. Most scientists, 201, have 58–59 D-Index. The last bar groups every scientist with 157 D-Index or more. The highlighted bar, 70–71 D-Index, is where this scientist sits. 40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 163 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40–41 D-Index 157+

This scientist: 70 D-Index — 52nd percentile

52% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

View D-Index distribution as a table
Number of Immunology scientists by D-index, Research.com 2026 ranking edition. Based on 4,929 ranked scientists.
D-Index Scientists This scientist
40–41 28
42–43 91
44–45 157
46–47 192
48–49 175
50–51 188
52–53 177
54–55 155
56–57 194
58–59 201
60–61 197
62–63 201
64–65 173
66–67 167
68–69 172
70–71 199 70
72–73 184
74–75 133
76–77 163
78–79 127
80–81 121
82–83 125
84–85 121
86–87 102
88–89 96
90–91 75
92–93 72
94–95 74
96–97 66
98–99 68
100–101 49
102–103 60
104–105 54
106–107 36
108–109 23
110–111 52
112–113 41
114–115 34
116–117 25
118–119 28
120–121 11
122–123 20
124–125 27
126–127 19
128–129 20
130–131 16
132–133 17
134–135 14
136–137 15
138–139 9
140–141 11
142–143 9
144–145 9
146–147 7
148–149 7
150–151 7
152–153 5
154–155 8
156 6
157+ 96
Download as CSV

Overview

Richard B. Pollard is affiliated with the University of California, Davis in the United States. Their research primarily focuses on the fields of Medicine and Immunology and Microbiology, with particular expertise in Infectious Diseases, Virology, Emergency Medicine, and Epidemiology.

The scientist's research topics concentrate largely on HIV and related conditions. These include:

  • HIV Research and Treatment
  • HIV/AIDS drug development and treatment
  • HIV/AIDS Research and Interventions
  • HIV-related health complications and treatments
  • Pneumocystis jirovecii pneumonia detection and treatment

Richard B. Pollard has authored several papers within these thematic areas, mainly published through UNC Libraries. Recent publications include:

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection (2020) in UNC Libraries
  • Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial (2020) in UNC Libraries
  • Proteinuria, CrCl, and Immune Activation in Antiretroviral-Naïve HIV-Infected Subjects (2020) in UNC Libraries
  • Older HIV-infected patients on antiretroviral therapy have B-cell expansion and attenuated CD4 cell increases with immune activation reduction (2020) in UNC Libraries

Collaboration is a significant aspect of their research activity. Frequent co-authors associated with Richard B. Pollard include:

  • Gregory K. Robbins
  • Alan Landay
  • Robert C. Kalayjian
  • Victor De Gruttola
  • Robert W. Shafer

Richard B. Pollard's contributions focus on understanding HIV infection dynamics, treatment regimens, immune system interactions, and related infectious diseases. The combination of published work and interdisciplinary collaboration reflects an engagement with ongoing developments in HIV/AIDS therapies and immunological responses.

Best Publications

  • Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

    Jeffrey L. Lennox;Edwin DeJesus;Adriano Lazzarin;Richard B. Pollard

  • Effect of Human Leukocyte Interferon on Hepatitis B Virus Infection in Patients with Chronic Active Hepatitis

    Harry B. Greenberg;Richard B. Pollard;Larry I. Lutwick;Peter B. Gregory

  • Sex differences in the Toll-like receptor–mediated response of plasmacytoid dendritic cells to HIV-1

    Angela Meier;J Judy Chang;Ellen S Chan;Richard B Pollard

  • Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy.

    Mark A. Jacobson;Michael Zegans;Michael Zegans;Peter R. Pavan;James J. O'Donnell

  • Comparison of Sequential Three-Drug Regimens as Initial Therapy for HIV-1 Infection

    Gregory K. Robbins;Victor De Gruttola;Robert W. Shafer;Laura M. Smeaton

  • Safety, pharmacokinetics, and antiviral activity of AMD3100, a selective CXCR4 receptor inhibitor, in HIV-1 infection

    Craig W. Hendrix;Ann C. Collier;Michael Marcel Lederman;Dominique Schols

  • Human leukocyte Interferon for the treatment of herpes zoster in patients with cancer.

    Thomas C. Merigan;Kenneth H. Rand;Richard B. Pollard;Paul S. Abdallah

  • Lamotrigine for HIV-associated painful sensory neuropathies: a placebo-controlled trial.

    David M. Simpson;J. C. McArthur;R. Olney;D. Clifford

  • Pharmacogenetics of long-term responses to antiretroviral regimens containing Efavirenz and/or Nelfinavir: an Adult Aids Clinical Trials Group Study

    David W. Haas;Laura M. Smeaton;Robert W. Shafer;Gregory K. Robbins

  • Cytomegalovirus Immune Plasma in Bone Marrow Transplant Recipients

    Drew J. Winston;Richard B. Pollard;Winston G. Ho;James G. Gallagher

  • Incomplete Reconstitution of T Cell Subsets on Combination Antiretroviral Therapy in the AIDS Clinical Trials Group Protocol 384

    Gregory K. Robbins;John G. Spritzler;Ellen S. Chan;David M. Asmuth

  • Increased Pulmonary Superinfections in Cardiac-Transplant Patients Undergoing Primary Cytomegalovirus Infection

    Kenneth H. Rand;Richard B. Pollard;Thomas C. Merigan

  • Safety profile of nevirapine, a nonnucleoside reverse transcriptase inhibitor for the treatment of human immunodeficiency virus infection

    Richard B. Pollard;Patrick Robinson;Kevin Dransfield

  • Mucosal immune responses to HIV-1 in elite controllers: a potential correlate of immune control.

    April L. Ferre;Peter W. Hunt;J. William Critchfield;Delandy H. Young

  • Antiviral treatment of chronic hepatitis B virus infection. I. Changes in viral markers with interferon combined with adenine arabinoside.

    G. H. Scullard;Richard B Pollard;J. L. Smith;S. L. Sacks

  • Raltegravir Versus Efavirenz Regimens in Treatment-Naive HIV-1-Infected Patients: 96-Week Efficacy, Durability, Subgroup, Safety, and Metabolic Analyses

    Jeffrey L. Lennox;Edwin DeJesus;Daniel S. Berger;Adriano Lazzarin

  • Cytomegalovirus Retinitis in Immunosuppressed Hosts: II. Ocular Manifestations

    Peter R. Egbert;Richard B. Pollard;James G. Gallagher;Thomas C. Merigan

  • Glycyrrhizin, an active component of licorice roots, reduces morbidity and mortality of mice infected with lethal doses of influenza virus.

    Tokuichiro Utsunomiya;Makiko Kobayashi;Richard B. Pollard;Fujio Suzuki

  • Cellular immunity and herpesvirus infections in cardiac-transplant patients.

    Kenneth H. Rand;Lucille E. Rasmussen;Richard B. Pollard;Ann Arvin

  • A Pathogenic Role of Th2 Cells and Their Cytokine Products on the Pulmonary Metastasis of Murine B16 Melanoma

    Makiko Kobayashi;Hiroyuki Kobayashi;Richard B. Pollard;Fujio Suzuki

  • Randomized controlled study of tenofovir and adefovir in chronic hepatitis B virus and HIV infection: ACTG A5127.

    Marion G. Peters;Janet Andersen;Patrick Lynch;Tun Liu

  • Effect of baseline- and treatment-related factors on immunologic recovery after initiation of antiretroviral therapy in HIV-1-positive subjects: results from ACTG 384.

    Rajesh T. Gandhi;John Spritzler;Ellen Chan;David M. Asmuth

  • Age-Related Immune Dysfunction in Health and in Human Immunodeficiency Virus (HIV) Disease: Association of Age and HIV Infection with Naive CD8+ Cell Depletion, Reduced Expression of CD28 on CD8+ Cells, and Reduced Thymic Volumes

    Robert C Kalayjian;Robert C Kalayjian;Alan Landay;Richard B. Pollard;Dennis D. Taub

Frequent Co-Authors

Thomas C. Merigan
Thomas C. Merigan Stanford University
David N. Herndon
David N. Herndon The University of Texas Medical Branch at Galveston
Alan L. Landay
Alan L. Landay The University of Texas Medical Branch at Galveston
Michael M. Lederman
Michael M. Lederman Case Western Reserve University
Christopher J. Miller
Christopher J. Miller University of California, Davis
Ronald T. Mitsuyasu
Ronald T. Mitsuyasu University of California, Los Angeles
Margaret A. Fischl
Margaret A. Fischl University of Miami
Ronald J. Bosch
Ronald J. Bosch Harvard University
Robert L. Murphy
Robert L. Murphy Northwestern University
Pablo Tebas
Pablo Tebas University of Pennsylvania

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various interdisciplinary career paths, especially in healthcare and research. Many students leverage their immunology background to pursue nursing programs that align with their interest in patient care and disease prevention.

For those looking to enter nursing quickly, exploring options like the easiest absn program to get into can provide a streamlined pathway to becoming a registered nurse. These accelerated programs emphasize efficient admission processes, perfect for fast-tracking your healthcare career.

Alternatively, aspiring nurses can consider lpn programs with easiest admission requirements to begin their clinical journey. Licensed Practical Nurse roles are essential in many medical settings, offering practical experience and foundational knowledge in patient care.

For specialization, the easiest fnp program provides an accessible route to becoming a Family Nurse Practitioner. These programs often balance rigorous academics with flexible admissions, ideal for those focused on family-centered healthcare.

Additionally, if psychiatric care interests you, consider exploring the best psychiatric mental health nurse practitioner programs online. These programs offer strong clinical placements, enhancing your expertise in mental health alongside immunology-related knowledge.

Best Scientists Citing Richard B. Pollard

Trending Scientists

Recently Published Articles